Murcko scaffold
Ring system with 4 rings and 22 atoms
80 chemicals on CompoundList share this ring system.
- Rings
- 4
- Scaffold atoms
- 22
- Chemicals
- 80
- With full pages
- 10
Scaffold SMILES
c1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)cc1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 48 of 80 chemicals
2-Pyrimidinamine, 4-(1H-indol-3-yl)-N-(3,4,5-trimethoxyphenyl)-
CAS 191727-52-3C21H20N4O3
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
CAS 1421372-94-2C20H16FN5O3
N-(4-Bromo-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine
CAS 1421373-08-1C20H16BrN5O3
N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)-2-nitro-1,4-benzenediamine
CAS 1421372-67-9C25H29N7O3
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1H-indol-3-yl)pyrimidin-2-amine
CAS 1421372-34-0C19H14FN5O3
N1-(4-(1H-indol-3-yl)pyrimidin-2-yl)-N4-(2-(dimethylamino)ethyl)-2-methoxy-N4-methyl-5-nitrobenzene-1,4-diamine
CAS 1421373-32-1C24H27N7O3
tert-Butyl (2-((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)(methyl)amino)ethyl)(methyl)carbamate
CAS 1421373-35-4C29H35N7O5
Osimertinib
CAS 1421373-65-0C28H33N7O2
N-[4-Methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[methyl[2-(methylamino)ethyl]amino]phenyl]-2-propenamide
CAS 1421373-99-0C27H31N7O2
AZ-5104
CAS 1421373-98-9C27H31N7O2
5-Chloro-4-(1H-indol-3-yl)-N-(2-methoxy-5-nitrophenyl)pyrimidin-2-amine
CAS 1453198-91-8C19H14ClN5O3
Mutant EGFR inhibitor
CAS 1421373-62-7C27H30ClN7O2
Osimertinib mesylate
CAS 1421373-66-1C29H37N7O5S
Mutated EGFR-IN-1
CAS 1421372-66-8C25H31N7O
N-(5-{[5-Chloro-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-2-{2-dimethylaminoethyl-methylamino}-4-methoxyphenyl)prop-2-enamide
CAS 1421373-63-8C28H32ClN7O2
3-Chloro-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)propanamide
CAS 1421373-36-5C28H34ClN7O2
N1-(2-dimethylaminoethyl)-N4-[4-(1H-indol-3-yl)pyrimidin-2-yl]-5-methoxy-N1-methylbenzene-1,2,4-triamine
CAS 1421373-31-0C24H29N7O
tert-Butyl (2-((2-acrylamido-5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)(methyl)amino)ethyl)(methyl)carbamate
CAS 1421373-33-2C32H39N7O4
Osimertinib-d6
CAS 1638281-44-3C28H33N7O2
Asandeutertinib
CAS 1638281-46-5C28H33N7O2
Deuterated osimertinib
CAS 1638281-48-7C28H33N7O2
Osimertinib (dimesylate)
CAS 2070014-82-1C30H41N7O8S2
Methyl 2-((4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxy-5-nitrophenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
CAS 1847464-27-0C27H31N7O5
Mobocertinib
CAS 1847461-43-1C32H39N7O4
- 3-[2-[(4-Fluoro-2-methoxy-5-nitrophenyl)amino]-4-pyrimidinyl]-1-methyl-1H-indole-6-carbonitrile1847464-05-4C21H15FN6O3
- Methyl 2-((4-fluoro-2-methoxy-5-nitrophenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate1847463-75-5C22H18FN5O5
- N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine hydrochloride2444540-58-1C20H17ClFN5O3
- 5-Methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenol1956306-73-2C20H17N5O4
- Rezivertinib1835667-12-3C27H30N6O3
- 2-Methoxy-N4-methyl-N1-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-5-nitrobenzene-1,4-diamine2044704-62-1C21H20N6O3
- N-[2-(Difluoromethoxy)-4-fluoro-5-nitrophenyl]-4-(1-methylindol-3-yl)pyrimidin-2-amine1865729-78-7C20H14F3N5O3
- N-(2,4-Dimethoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine1942853-78-2C21H19N5O4
- 4,6-Dimethoxy-N1-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,3-diamine1942853-79-3C21H21N5O2
- N-(2,4-Dimethoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide1942853-18-0C24H23N5O3
- N-(2-(Dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide2044702-39-6C25H26N6O2
- 5-Methoxy-N1,N1-dimethyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine hydrochloride2044702-55-6C22H25ClN6O
- N'-Desacryloyl N-Desdimethylaminoethyl-N-methyl Osimertinib1801616-92-1C22H24N6O
- N-(5-Acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)-N-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)acrylamide1932710-29-6C31H35N7O3
- N-[5-Amino-4-[2-(dimethylamino)ethyl-methylamino]-2-methoxyphenyl]-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]prop-2-enamide2044702-65-8C28H33N7O2
- Isopropyl 2-((5-amino-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate1847465-25-1C29H37N7O3
- N-[2-[(2-Iodoethyl)(methyl)amino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]acrylamide3033297-48-9C26H27IN6O2
- 1 suppliersBefotertinib1835667-63-4C29H32F3N7O2
- N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-amine1835670-26-2C21H15F4N5O3
- N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine1835670-28-4C26H30F3N7O
- N-Desdimethylaminoethyl-N-methyl Nitro-N'-desacryloyl Osimertinib1820891-36-8C22H22N6O3
- Erk-IN-82226293-75-8C26H29N7O2
- Rezivertinib dimesylate1835668-47-7C28H34N6O6S
- Orb32101642170255-78-2C27H31ClN6O3